RBI’s one-year extension of Kathpalia’s appointment raised eyebrows. Some say it was a strategic move by the RBI to ensure ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

This FTSE medical technology stock has strong earnings growth projections, posted impressive 2024 results, and looks very undervalued to me.